HR 5414
114th Congress
House
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Government employee pay, benefits, personnel management
Health promotion and preventive care
Medical education
FDA Cross-Center Collaboration Act of 2016
Introduced: June 8, 2016
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 8, 2016
Referred to the House Committee on Energy and Commerce.
Jun 8, 2016
Introduced in House
Plain-English summary
FDA Cross-Center Collaboration Act of 2016
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish one or more Intercenter Institutes. Each institute must coordinate activities applicable to a major disease area among the FDA centers that review products. Activities may include coordinating staff with relevant expertise, streamlining product review, and enhancing interactions with patients, sponsors, and the biomedical community.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1
Cosponsors
1